Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.
about
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexesPSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor traffickingDeletion of the NMDA-NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine-induced dopamine D1 receptor trafficking and acoustic startle behavior.D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats.Double-dissociation of the catecholaminergic modulation of synaptic transmission in the oval bed nucleus of the stria terminalis.Mechanisms underlying dopamine-mediated reward bias in compulsive behaviorsThe roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humansInvolvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesiaMaladaptive striatal plasticity in L-DOPA-induced dyskinesia.Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons.Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.Levodopa/benserazide microsphere (LBM) prevents L-dopa induced dyskinesia by inactivation of the DR1/PKA/P-tau pathway in 6-OHDA-lesioned Parkinson's rats.Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.G protein-coupled receptor kinases: more than just kinases and not only for GPCRsModulating neuromodulation by receptor membrane traffic in the endocytic pathway.Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.Neurophysiology of performance monitoring and adaptive behavior.Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions.Pharmacogenetics of drug response in Parkinson's disease.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.Dopamine heteroreceptor complexes as therapeutic targets in Parkinson's disease.G protein-coupled receptor kinases as regulators of dopamine receptor functions.Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Potential for targeting dopamine/DARPP-32 signaling in neuropsychiatric and neurodegenerative disorders.New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease.Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models.Clinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.Functional neuroanatomy of the basal gangliaRole of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease.Understanding and prevention of "therapy-" induced dyskinesias.
P2860
Q27021464-519636FF-5BF3-44E3-8D38-CAA822915E34Q27324174-B07FFD9E-D75B-4361-ACC6-CCC482E7CABAQ28289714-F30E0A68-B963-431A-B3F2-1031F5B45041Q28582674-6020B77F-C3AF-4E19-98C7-90FD5F338859Q30437706-DFD42F69-D775-4EFB-A4B5-D39E70BE9EADQ33573158-344AF52F-D8F0-481C-9CF1-94CB251C08D0Q33573249-04B6EA0B-6BEE-4500-871A-EAC568A19307Q33657211-56715A53-1E8F-4D47-8448-ED8EA2B90A3EQ33706269-64528178-1F67-4D24-AABD-105105140F02Q33725654-B7231C11-99C6-4BEC-9931-EE463354BDFFQ34094008-07C73B07-BDD4-4C00-867F-9F720403D6A5Q34105586-D649BAD3-4B59-406C-9129-7F81555A518FQ34116613-FA076FB9-0C83-4DE9-A203-8844867E8889Q34238909-9C5C5B67-68AA-4A78-BBC6-1F494F8808BFQ34383447-81FA8379-9D05-4B96-AA3A-B164C48CBE62Q34662380-B5A359C2-32AC-4845-A06B-E5ED76CAC739Q34708186-AB808787-E1E7-4652-8828-64E57F48E7EBQ35208420-464AD001-16F1-4233-A229-222B2150C68EQ35324977-DCAA65C7-CA79-4A74-BAD4-8D086DA17A42Q35424424-A94F740A-DC4C-4F86-BDFA-1A138ED0E1EFQ35621624-2486C3DF-9904-4D98-AF5E-BE17D8918494Q36392981-2C9D88C9-E4B5-42DF-B15F-724709C4C073Q37925513-892CF1BD-B750-4F14-923F-2F34F31F9907Q37973611-C01D22F6-C142-45E8-9ABE-896BBC8C752FQ38175133-419B6581-8F21-4916-AE50-CBEABA62A38CQ38207680-303D8EC8-BA43-4BBD-8D85-25D3D63A33DDQ38250117-67587CBE-4D23-476D-99A8-7DD00B5C92DDQ38262418-4CCC05D0-71E1-424A-9D51-A1ADCF3174E2Q38285126-896A9A17-C0C1-4734-974D-5782DC3990ECQ38834292-532D9ACA-CE9C-4BC4-8907-0B635AA8845EQ38931640-50A84D42-AED3-4F8C-980E-31B79B7F0720Q38951947-F6919D6D-1E83-4D85-A23E-54FAE278768BQ39012371-D7CC9411-7FB4-406F-B423-E8744B175FEAQ39067400-1432FD46-0ABD-402E-9ECC-B83881377E75Q39172080-9649A8B1-8C52-4B2D-BCC3-D5996224AD44Q41584434-54245A63-83E1-44FE-86BC-FFE268D50ABDQ41645312-4F9A3775-64D1-4C0C-94B3-55F5326BF4C8Q41790827-CC962659-60FA-4DC5-92A7-722C8112B7B2Q41853023-BECB1981-2F4E-4F41-A7A9-17F3C19BF3D4Q42052125-4316DBE6-5178-4224-A16F-811ED2FBE68D
P2860
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@en
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@nl
type
label
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@en
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@nl
prefLabel
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@en
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@nl
P2093
P921
P1476
Pharmacological analysis demon ...... of L-DOPA-induced dyskinesia.
@en
P2093
Amandine Berthet
Bertrand Bloch
Grégory Porras
Holger Stark
Martine Cador
P304
P356
10.1523/JNEUROSCI.5884-08.2009
P407
P577
2009-04-01T00:00:00Z